News

COPD prevalence and disease burden found to vary significantly by state
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.
Zacks Investment Research on MSN3d
Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?
Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s ...
Watch live: Matters of Life and Breath: Championing COPD Care
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...
BMJ5d
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies - BMJ Open
Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute ...